Inhibition of huntingtin synthesis by antisense oligodeoxynucleotides

Molecular and Cellular Neurosciences

Volumn 16, Issue 4, 2000, Pages 313-323

  Nellemann, Christine ^a   Abell, Kathrine ^a   Nørremo lle, Anne ^a   Løkkegaard, Thomas ^a   Naver, Bjarke ^a   Röpke, Carsten ^a   Rygaard, Jørgen ^b   Sørensen, Sven Asger ^a   Hasholt, Lis ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Kommunehospitalet ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; HUNTINGTIN; ANTIBODY; FLUORESCEIN ISOTHIOCYANATE; FLUORESCENT DYE; HD PROTEIN, HUMAN; MESSENGER RNA; NERVE PROTEIN; NUCLEAR PROTEIN;

ARTICLE; DOWN REGULATION; EMBRYO; GENE LOCATION; GENE SEQUENCE; HUMAN; HUNTINGTON CHOREA; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CELL CULTURE; CHEMISTRY; CYTOLOGY; EXON; GENE EXPRESSION; GENETICS; IMMUNOLOGY; IN VITRO STUDY; MITOSIS; NERVE CELL; PHYSIOLOGY; PROTEIN SYNTHESIS; RABBIT; TERATOCARCINOMA;

ANIMALS; ANTIBODIES; EXONS; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; GENE EXPRESSION; HUMANS; HUNTINGTON DISEASE; MITOSIS; NERVE TISSUE PROTEINS; NEURONS; NUCLEAR PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN BIOSYNTHESIS; RABBITS; RNA, MESSENGER; TERATOCARCINOMA; TUMOR CELLS, CULTURED;

EID: 0033626428     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.2000.0872     Document Type: Article

References (52)

1. The influence of polarized epithelial (Caco-2) cell differentiation on the cellular binding of phosphordiester and phosphorothioate oligonucleotides
2. Structure and expression of the Huntington's disease gene: Evidence against simple inactivation due to an expanded CAG repeat
3. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro
4. Application of antisense strategies for the analysis of protein kinase functions
5. Optimization of in vitro translation reactions using the salt select lysate system
6. Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides
7. Expression of normal and mutant huntingtin in the developing brain
8. Antisense drug discovery: Can cell-free screens speed the process?
9. Construction of human embryonic cDNA libraries: HD, PKD1 and BRCA1 are transcribed widely during embryogenesis
10. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH
11. Antisense blockade of expression: SNAP-25 in vitro and in vivo
12. Mutation size and age at onset in Huntington's disease
13. Therapeutic applications of oligonucleotides
14. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons
15. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes
16. Inactivation of the mouse Huntington's disease gene homolog Hdh
17. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract
18. Antisense gene therapy for neurodegenerative disease?
19. Therapeutic strategies for Huntington's disease based on a molecular understanding of the disorder
20. Interaction of oligodeoxynucleotides with mammalian cells
21. Antisense oligodeoxynucleotides as novel neuropharmacological tools for selective expression blockade in the brain
22. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
23. Context effects and inefficient initiation at non-AUG codons in eucaryotic cell-free translation systems
24. Uptake of oligodeoxyribonucleotides by lymphoid cells is heterogeneous and inducible
25. Raising antibodies by coupling peptides to PPD and immunizing BCG-sensitized animals
26. Pharmacokinetics of oligonucleotides in cell culture
27. Sequence of the murine Huntington disease gene: Evidence for conservation, and polymorphism in a triplet (CCG) repeat alternate splicing
28. SH3 domain-dependent association of huntingtin with epidermal growth factor receptor signaling complexes
29. Selecting effective antisense reagents on combinatorial oligonucleotide arrays
30. Antisense ablation of mRNA in frog and rabbit cell-free systems
31. Cellular uptake mechanism for oligonucleotides: Involvement of endocytosis in the uptake of phosphodiester oligonucleotides by a human colorectal adenocarcinoma cell line, HCT-15
32. Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes
33. Trinucleotide repeat elongation in the Huntingtin gene in Huntington disease patients from 71 Danish families
34. Reversing neurodegeneration: A promise unfolds
35. Differential expression of normal and mutant Huntington's disease gene alleles
36. Pure, postmitotic, polarized human neurons derived from Ntera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons
37. Antisense oligonucleotides - Highly specific tools for basic research and pharmacotherapy
38. Expression of the Huntington disease gene in rodents: Cloning the rat homologue and evidence for downregulation in non-neuronal tissues during development
39. Widespread expression of Huntington's disease gene (IT15) protein product
40. Modified deoxynucleotides stable to exonuclease degradation in serum
41. The influence of target protein half-life on the effectiveness of antisense oligonucleotide analog-mediated biologic responses
42. How to design an antisense oligodeoxynucleotide experiment: A consensus approach
43. Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides
44. Antisense oligodeoxynucleotides
45. Cellular uptake properties of oligonucleotides in LLC-PK1 renal epithelial cells
46. Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm
47. Cellular localisation of the Huntington's disease protein and discrimination of the normal and mutated form
48. Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytotic pathways
49. Antisense 'knockdown' strategies in neurotransmitter receptor research
50. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease
51. Sequence-specific cleavage of huntingtin mRNA by catalytic DNA
52. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue